Audit Reveals Peptide Therapy Websites Emphasize Benefits Over Safety Information
Peptide Therapy Websites Tout Benefits Nearly 4x More Often Than Safety Details, 100-Page Audit Finds
Image: Benzinga
A recent audit by MDConsultingNY found that peptide therapy websites highlight potential benefits nearly four times more than safety details. The review of 100 websites showed 100% discussed benefits, while only 26.5% included essential safety information. With FDA discussions on peptide substances approaching, the need for clear safety communication is critical.
- 01The audit analyzed 100 peptide therapy webpages across 25 U.S. states, revealing that all pages mentioned benefits but only 26.5% included core safety details.
- 02The audit highlighted a significant imbalance, with a benefit-to-safety transparency ratio of 3.77 to 1.
- 03Only 36% of pages discussed risks or side effects, and just 14% warned against unsupervised peptide use.
- 04The FDA is set to discuss peptide-related substances at a Pharmacy Compounding Advisory Committee meeting on July 23–24, 2026.
- 05MDConsultingNY recommends implementing a 'Safety SEO' framework to improve clarity and transparency in peptide therapy communications.
Advertisement
In-Article Ad
A comprehensive audit conducted by MDConsultingNY has revealed that websites promoting peptide therapy overwhelmingly focus on potential benefits while neglecting essential safety information. The review, which encompassed 100 websites from various medical practices across 25 U.S. states, found that every site discussed the advantages of peptide therapy, but only 26.5% provided critical safety details, such as FDA status and risk discussions. This stark contrast creates a benefit-to-safety transparency imbalance of 3.77 to 1. The audit also noted that 42% of the pages lacked any of the four key safety indicators, raising concerns about patient awareness. With the FDA planning a meeting to discuss the inclusion of certain peptide substances on its 503A Bulks List, the need for clear and responsible communication regarding the safety and efficacy of peptide therapies is more pressing than ever. In response, MDConsultingNY has proposed a 'Safety SEO' framework aimed at ensuring that medical practices provide comprehensive information to help patients make informed decisions about their treatments.
Advertisement
In-Article Ad
The audit's findings highlight a critical gap in safety communication, which could affect patient decision-making regarding peptide therapies.
Advertisement
In-Article Ad
Reader Poll
How important do you think safety information is when considering peptide therapy?
Connecting to poll...
Read the original article
Visit the source for the complete story.